AIP - Adcock Ingram Holdings Limited - Withdrawal of dextropropoxyphene-
AIP
AIP
AIP - Adcock Ingram Holdings Limited - Withdrawal of dextropropoxyphene-
containing medicines
ADCOCK INGRAM HOLDINGS LIMITED
(Registration number 2007/016236/06)
(Incorporated in the Republic of South Africa)
Share code: AIP ISIN: ZAE000123436
("Adcock Ingram")
WITHDRAWAL OF DEXTROPROPOXYPHENE-CONTAINING MEDICINES
On 19 November 2010, the US Food and Drug Administration ("FDA") withdrew
dextropropoxyphene ("DPP") from the United States ("US") market. The FDA
determined that the benefits of DPP for pain relief at US recommended doses
outweighed the safety risk and as such the regulator requested that suppliers
voluntarily withdraw any drugs containing DPP from the US market.
Following the FDA announcement, Adcock Ingram engaged in discussions with the
Medicines Control Council of the Department of Health ("MCC") relating to the
implications of the US data to patient safety in South Africa. Adcock Ingram has
now become aware that the MCC has resolved, inter alia, that all DPP containing
medicines be withdrawn from the South African market. Adcock Ingram has not, as
yet, received any formal communication from the MCC regarding withdrawal of its
DPP containing medicines.
DPP is a compound with pain-relieving properties that is found in three of
Adcock Ingram`s drugs, namely, Synap Forte, Lentogesic and Doxyfene. These
drugs contributed approximately R200 million to Adcock Ingram`s revenue for the
financial year ended 30 September 2010.
Midrand
10 December 2010
Sponsor
Deutsche Securities (SA) (Proprietary) Limited
Date: 10/12/2010 07:30:01 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
